Hyperparathyroidism in the hemodialysis population: a survey of 612 patients

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
M M Salem

Abstract

There are no epidemiologic studies documenting the prevalence of hyperparathyroidism in the US hemodialysis population. We looked at a random sample of 612 hemodialysis patients enrolled in 10 outpatient dialysis units in Mississippi. Fifty percent of the patients surveyed had an intact serum parathyroid hormone (PTH) level more than three times normal (mean, 622 pg/mL). Another 25% had a less than normal PTH level (mean, 33 pg/mL), suggesting adynamic bone disease. Abnormal serum calcium was also common. Seventeen percent of patients were hypocalcemic and 14% were hypercalcemic. These high point prevalences occurred despite widespread use of calcium supplements and/or vitamin D (used in 90% of the patients surveyed). Black patients tended to have a lower serum calcium and higher PTH level than white patients. We also found that diabetic patients are less likely to have an elevated PTH level than nondiabetic patients. Elevated serum phosphorus was the most important factor correlating with the development of secondary hyperparathyroidism. Causes of inadequate control of hyperparathyroidism in this population require further study.

References

Mar 1, 1971·The Journal of Clinical Investigation·E SlatopolskyN S Bricker
Jan 1, 1982·The Journal of Clinical Endocrinology and Metabolism·E M BrownS P Marynick
Jan 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y PeiD Sherrard
Feb 1, 1993·Kidney International·D J SherrardG V Segre
Apr 1, 1993·Kidney International·A J Felsenfeld, F Llach

❮ Previous
Next ❯

Citations

Nov 17, 1998·Journal of the Royal Society of Medicine·G J Morris-StiffW A Jurewicz
Aug 28, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·N NaganoM Wada
Nov 30, 2006·Journal of the American Society of Nephrology : JASN·Angel L M de FranciscoManuel Arias
Apr 5, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Takashi AkibaUNKNOWN KRN1493 Study Group
Apr 5, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Nabieh Al-HilaliKaivilayil V Johny
Oct 2, 2020·Biological & Pharmaceutical Bulletin·Tadashi ImafukuToru Maruyama
Feb 28, 2003·Clinical Nuclear Medicine·Kristen L FernandezJohn A Singer
Apr 9, 2004·The New England Journal of Medicine·Geoffrey A BlockWilliam G Goodman
Jul 21, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sharon M MoeStuart M Sprague
Jan 8, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Piergiorgio MessaFrancesco Locatelli
Feb 6, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Abdulrazak AlghareebKhalid Alsaran
Sep 21, 2016·World Journal of Nephrology·Cláudia RibeiroLucas José de Campos Machado
Apr 15, 2005·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Hiroshi NishiMasafumi Fukagawa
Aug 8, 2007·International Urology and Nephrology·Barbara Santarosa Emo PetersLígia Araújo Martini
Feb 3, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Mario MeolaGiuliano Barsotti
Aug 21, 2013·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Jeong Im ChoiJoo Hark Yi
Feb 16, 2008·American Journal of Nephrology·Carlo VulpioMarco Castagneto
Feb 22, 2003·Journal of the American Society of Nephrology : JASN·L Darryl QuarlesDavid A Bushinsky
May 25, 2001·Journal of the American Society of Nephrology : JASN·Fabio MalbertiFrancesco Locatelli
Dec 16, 1998·Kidney International·T Weinreich
Nov 10, 2000·Advances in Renal Replacement Therapy·R Sadler
Jun 5, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Curtis A JohnsonSusan Smith
Jul 12, 2002·Kidney International·Hartmut H MallucheNicholas J Koszewski
May 11, 2002·The American Journal of the Medical Sciences·K Shashi KantRon Freyberg
Oct 22, 2004·Kidney International·Bryan KestenbaumCatherine Stehman-Breen
Apr 13, 2005·Clinical Therapeutics·Angel L M de Francisco
Aug 19, 2007·Diabetes & Metabolism·J F BlickléT Hannedouche
Mar 23, 2010·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Linda M McCann, Judith Beto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.